← Home
🚀 Sign up Free for Public Company Valuation & Insights!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free Video Highlights
AbbVie 
Pharma / Pharma
At a Glance | Core Facts | Company | Industry | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCompany at a Glance
Overview
AbbVie is a global, research-driven biopharmaceutical company that was founded in 2013 when it spun off from Abbott Laboratories. The company's focus is on developing advanced therapies and medicines for conditions such as immunology, oncology, neuroscience, and virology.
Headquartered in North Chicago, Illinois, AbbVie employs approximately 48,000 people worldwide and operates in more than 75 countries. The company is dedicated to providing innovative, safe, and effective treatments for patients, and its products are available in over 170 countries.
AbbVie's mission is to discover and deliver breakthrough medicines that enable people to live better lives. The company's values include integrity, collaboration, innovation, and a commitment to patient well-being. AbbVie has a strong pipeline of medications in various stages of development, and the company invests heavily in research and development to bring new treatments to patients.
Some of AbbVie's notable products include Humira, the best-selling prescription medication in the world, used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease, and Imbruvica, a targeted therapy for certain types of cancers. The company also has a portfolio of other medicines and treatments for conditions such as hepatitis C, multiple sclerosis, and Parkinson's disease.
AbbVie is committed to giving back to communities by supporting various charitable and scientific organizations. The company's philanthropic efforts focus on initiatives that align with its areas of expertise, such as healthcare, education, and environmental sustainability.
In addition to its focus on research and patient care, AbbVie is also committed to operating ethically and responsibly. The company has stated its commitment to reducing its environmental impact, promoting diversity and inclusion, and upholding rigorous ethical standards in all its operations.
Overall, AbbVie is a leading, globally recognized biopharmaceutical company with a strong portfolio and a commitment to making a positive impact in the world.
Headquartered in North Chicago, Illinois, AbbVie employs approximately 48,000 people worldwide and operates in more than 75 countries. The company is dedicated to providing innovative, safe, and effective treatments for patients, and its products are available in over 170 countries.
AbbVie's mission is to discover and deliver breakthrough medicines that enable people to live better lives. The company's values include integrity, collaboration, innovation, and a commitment to patient well-being. AbbVie has a strong pipeline of medications in various stages of development, and the company invests heavily in research and development to bring new treatments to patients.
Some of AbbVie's notable products include Humira, the best-selling prescription medication in the world, used to treat autoimmune conditions such as rheumatoid arthritis and Crohn's disease, and Imbruvica, a targeted therapy for certain types of cancers. The company also has a portfolio of other medicines and treatments for conditions such as hepatitis C, multiple sclerosis, and Parkinson's disease.
AbbVie is committed to giving back to communities by supporting various charitable and scientific organizations. The company's philanthropic efforts focus on initiatives that align with its areas of expertise, such as healthcare, education, and environmental sustainability.
In addition to its focus on research and patient care, AbbVie is also committed to operating ethically and responsibly. The company has stated its commitment to reducing its environmental impact, promoting diversity and inclusion, and upholding rigorous ethical standards in all its operations.
Overall, AbbVie is a leading, globally recognized biopharmaceutical company with a strong portfolio and a commitment to making a positive impact in the world.
What is special about the company?
There are several noteworthy aspects of the AbbVie company that make it stand out from other pharmaceutical companies:
1. Focus on innovative research and development: AbbVie places a strong emphasis on discovering and developing new treatments for challenging health conditions. The company invests heavily in research and development, with a significant portion of its revenue being allocated to this area.
2. Strong portfolio of leading medicines: AbbVie has a robust portfolio of medicines that address a diverse range of diseases, including immunology, neurology, oncology, and virology. Many of its products are considered best-in-class in their respective therapeutic areas.
3. Strong pipeline: In addition to its current line of medicines, AbbVie has a strong pipeline of potential new treatments, which it continuously evaluates for their potential to address unmet medical needs and create value for patients.
4. Commitment to patient care: AbbVie is committed to making a meaningful difference in the lives of patients by providing access to innovative medicines and supporting disease education and awareness programs.
5. Sustainability initiatives: The company has a strong focus on sustainability and has implemented several initiatives to reduce environmental impact, promote employee well-being, and support local communities.
6. Strong financial performance: AbbVie has consistently delivered strong financial results, with a track record of sustainable long-term growth and shareholder value creation.
7. Global presence: AbbVie operates in more than 175 countries and has a strong global presence, which enables it to reach a wide patient population and contribute to improving global health outcomes.
1. Focus on innovative research and development: AbbVie places a strong emphasis on discovering and developing new treatments for challenging health conditions. The company invests heavily in research and development, with a significant portion of its revenue being allocated to this area.
2. Strong portfolio of leading medicines: AbbVie has a robust portfolio of medicines that address a diverse range of diseases, including immunology, neurology, oncology, and virology. Many of its products are considered best-in-class in their respective therapeutic areas.
3. Strong pipeline: In addition to its current line of medicines, AbbVie has a strong pipeline of potential new treatments, which it continuously evaluates for their potential to address unmet medical needs and create value for patients.
4. Commitment to patient care: AbbVie is committed to making a meaningful difference in the lives of patients by providing access to innovative medicines and supporting disease education and awareness programs.
5. Sustainability initiatives: The company has a strong focus on sustainability and has implemented several initiatives to reduce environmental impact, promote employee well-being, and support local communities.
6. Strong financial performance: AbbVie has consistently delivered strong financial results, with a track record of sustainable long-term growth and shareholder value creation.
7. Global presence: AbbVie operates in more than 175 countries and has a strong global presence, which enables it to reach a wide patient population and contribute to improving global health outcomes.
What the company's business model?
AbbVie is a biopharmaceutical company that focuses on the development, manufacturing, and commercialization of innovative pharmaceutical products primarily in the areas of immunology, oncology, neuroscience, and virology.
The company's business model is centered around research and development (R&D) of new medicines and therapies, strategic collaborations and partnerships, and a strong sales and marketing strategy to bring these products to market.
AbbVie's R&D efforts are focused on identifying potential treatments for diseases with the greatest unmet needs, using cutting-edge technologies and innovative approaches. The company has a robust pipeline of promising drug candidates in various stages of development.
In addition, AbbVie has established strategic collaborations and partnerships with leading organizations in the healthcare industry to complement its in-house R&D efforts and advance its drug discovery and development programs. This includes partnerships with academic institutions, biotech companies, and other pharmaceutical companies.
AbbVie also has a strong sales and marketing strategy to drive the commercial success of its products. The company has a global presence and a diversified portfolio of drugs, which allows it to leverage its operations and resources in different markets.
Overall, the AbbVie business model is focused on developing and bringing innovative medicines to patients in need, while also driving profitable growth through sound R&D, partnerships, and commercialization strategies.
The company's business model is centered around research and development (R&D) of new medicines and therapies, strategic collaborations and partnerships, and a strong sales and marketing strategy to bring these products to market.
AbbVie's R&D efforts are focused on identifying potential treatments for diseases with the greatest unmet needs, using cutting-edge technologies and innovative approaches. The company has a robust pipeline of promising drug candidates in various stages of development.
In addition, AbbVie has established strategic collaborations and partnerships with leading organizations in the healthcare industry to complement its in-house R&D efforts and advance its drug discovery and development programs. This includes partnerships with academic institutions, biotech companies, and other pharmaceutical companies.
AbbVie also has a strong sales and marketing strategy to drive the commercial success of its products. The company has a global presence and a diversified portfolio of drugs, which allows it to leverage its operations and resources in different markets.
Overall, the AbbVie business model is focused on developing and bringing innovative medicines to patients in need, while also driving profitable growth through sound R&D, partnerships, and commercialization strategies.
Interesting facts about the company
1. AbbVie was created as a spinoff company from Abbott Laboratories in 2013, making it a relatively young company compared to others in the pharmaceutical industry.
2. The name AbbVie is derived from a combination of the words Abbott and vitality.
3. AbbVie’s headquarters are located in North Chicago, Illinois.
4. The company employs over 47,000 people worldwide and has a presence in more than 170 countries.
5. AbbVie’s primary focus is on developing and manufacturing pharmaceutical products in the areas of immunology, oncology, neuroscience, virology, and general medicine.
6. The company’s top-selling drug is Humira, a medication used to treat autoimmune disorders such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
7. AbbVie has made significant investments in the field of biotechnology, particularly in the areas of cancer and immunology, through partnerships and acquisitions.
8. In 2019, AbbVie completed a $63 billion acquisition of Allergan, a global pharmaceutical company known for its Botox brand.
9. AbbVie has a strong commitment to sustainability and has been recognized for its efforts in reducing its environmental impact through initiatives such as using renewable energy and reducing water consumption.
10. The company has a history of philanthropy and has donated millions of dollars to various causes and organizations, including those focused on health care, education, and refugee assistance.
See Company Analysis
2. The name AbbVie is derived from a combination of the words Abbott and vitality.
3. AbbVie’s headquarters are located in North Chicago, Illinois.
4. The company employs over 47,000 people worldwide and has a presence in more than 170 countries.
5. AbbVie’s primary focus is on developing and manufacturing pharmaceutical products in the areas of immunology, oncology, neuroscience, virology, and general medicine.
6. The company’s top-selling drug is Humira, a medication used to treat autoimmune disorders such as rheumatoid arthritis, psoriasis, and Crohn’s disease.
7. AbbVie has made significant investments in the field of biotechnology, particularly in the areas of cancer and immunology, through partnerships and acquisitions.
8. In 2019, AbbVie completed a $63 billion acquisition of Allergan, a global pharmaceutical company known for its Botox brand.
9. AbbVie has a strong commitment to sustainability and has been recognized for its efforts in reducing its environmental impact through initiatives such as using renewable energy and reducing water consumption.
10. The company has a history of philanthropy and has donated millions of dollars to various causes and organizations, including those focused on health care, education, and refugee assistance.
See Company Analysis
Wait! There's more — sign up for free or log in